Literature DB >> 17941805

The requirement of Artemis in double-strand break repair depends on the type of DNA damage.

Aya Kurosawa1, Hideki Koyama, Shinichi Takayama, Kensuke Miki, Dai Ayusawa, Michihiko Fujii, Susumu Iiizumi, Noritaka Adachi.   

Abstract

Artemis is a recently identified factor involved in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. Here, we performed targeted disruption of the Artemis gene (ARTEMIS) in the human pre-B cell line Nalm-6. Unexpectedly, we found that cells lacking Artemis exhibit increased sensitivity to low doses, but not high doses, of ionizing radiation. We also show that ARTEMIS-deficient cells are hypersensitive to the topoisomerase II inhibitor etoposide, but to a much lesser extent than cells lacking DNA ligase IV, a critical component of NHEJ. Unlike DNA ligase IV-deficient cells, ARTEMIS-deficient cells were not hypersensitive to ICRF-193, a topoisomerase II inhibitor that does not stabilize topoisomerase II-DNA cleavable complexes. Collectively, our results suggest that Artemis only partially participates in the NHEJ pathway to repair DSBs in human somatic cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17941805     DOI: 10.1089/dna.2007.0649

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  23 in total

1.  Unifying the DNA end-processing roles of the artemis nuclease: Ku-dependent artemis resection at blunt DNA ends.

Authors:  Howard H Y Chang; Go Watanabe; Michael R Lieber
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

Review 2.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 3.  The multifunctional SNM1 gene family: not just nucleases.

Authors:  Yiyi Yan; Shamima Akhter; Xiaoshan Zhang; Randy Legerski
Journal:  Future Oncol       Date:  2010-06       Impact factor: 3.404

4.  Evidence that the DNA endonuclease ARTEMIS also has intrinsic 5'-exonuclease activity.

Authors:  Sicong Li; Howard H Chang; Doris Niewolik; Michael P Hedrick; Anthony B Pinkerton; Christian A Hassig; Klaus Schwarz; Michael R Lieber
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

Review 5.  Non-homologous end joining often uses microhomology: implications for alternative end joining.

Authors:  Nicholas R Pannunzio; Sicong Li; Go Watanabe; Michael R Lieber
Journal:  DNA Repair (Amst)       Date:  2014-03-07

Review 6.  Nonhomologous DNA end-joining for repair of DNA double-strand breaks.

Authors:  Nicholas R Pannunzio; Go Watanabe; Michael R Lieber
Journal:  J Biol Chem       Date:  2017-12-14       Impact factor: 5.157

7.  Apollo contributes to G overhang maintenance and protects leading-end telomeres.

Authors:  Peng Wu; Megan van Overbeek; Sean Rooney; Titia de Lange
Journal:  Mol Cell       Date:  2010-07-08       Impact factor: 17.970

Review 8.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

9.  Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation.

Authors:  Xiaoping Cui; Zhengfei Lu; Aya Kurosawa; Lars Klemm; Andrew T Bagshaw; Albert G Tsai; Neil Gemmell; Markus Müschen; Noritaka Adachi; Chih-Lin Hsieh; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

10.  Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs.

Authors:  Shruti Malu; Pablo De Ioannes; Mikhail Kozlov; Marsha Greene; Dailia Francis; Mary Hanna; Jesse Pena; Carlos R Escalante; Aya Kurosawa; Hediye Erdjument-Bromage; Paul Tempst; Noritaka Adachi; Paolo Vezzoni; Anna Villa; Aneel K Aggarwal; Patricia Cortes
Journal:  J Exp Med       Date:  2012-04-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.